Kyntra Bio to Report First Quarter 2026 Financial Results
Go back to Kyntra Bio to Report First Quarter 2026 Financial Results| (NASDAQ: KYNB) | Delayed: 7.61 +0.29 (3.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.32 | 52 Week High | $ | |||
| Open | $7.40 | 52 Week Low | $ | |||
| Day High | $7.72 | P/E | N/A | |||
| Day Low | $7.40 | EPS | $ | |||
| Volume | 23,495 | |||||

